Dinner Innovation Theater (Non-Accredited): A Comprehensive Review of Auvelity: A Rapid-Acting Antidepressant That Modulates Both Glutamatergic and Monoaminergic Pathways

Dinner will be served. Seating is limited to 100 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenters: Michael Asbach, DMSc, PA-C Erin Crown, MHS, PA-C, CAQ-Psychiatry This presentation is provided by Axsome Therapeutics, Inc.